​

Marker Therapeutics Ownership | Who Owns Marker Therapeutics?

OverviewForecastRevenueFinancialsChart

Marker Therapeutics Ownership Summary

Marker Therapeutics is owned by 25.49% institutional investors, 5.49% insiders, and 69.01% retail investors. Nea management company is the largest institutional shareholder, holding 10.62% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.70% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMarker Therapeutics25.49%5.49%69.01%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company1.63M10.62%$2.11M
Blue owl capital lp554.25K3.62%$720.52K
Aisling capital management lp325.37K2.13%$422.98K
Vanguard group346.07K2.07%$515.65K
Renaissance175.29K1.15%$227.88K
Geode capital management160.91K1.05%$209.21K
Advisor group93.12K0.61%$121.06K
Vanguard fiduciary trust87.27K0.57%$113.45K
Lpl financial83.05K0.54%$107.96K
Xtx topco63.57K0.42%$82.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp554.25K0.19%$720.52K
Nea management company1.63M0.12%$2.11M
Aisling capital management lp325.37K0.09%$422.98K
Invst29.00K0.00%$37.70K
Matrix asset advisors inc/ny15.00K0.00%$19.50K
Two sigma securities11.46K0.00%$14.90K
Virtu financial28.33K0.00%$25.00K
Xtx topco63.57K0.00%$82.64K
Ashton thomas private wealth16.40K0.00%$21.32K
Renaissance175.29K0.00%$227.88K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust87.27K-87.27K
Renaissance175.29K0.00%51.64K
Susquehanna group, llp48.78K-48.78K
Vanguard group346.07K-46.29K
Geode capital management160.91K-30.57K

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---499.73K
Alyeska investment group---213.02K
Ubs group32.37K--141.66K
Ar asset management---73.70K
Citadel advisors---58.85K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust87.27K-87.27K$113.45K
Susquehanna group, llp48.78K-48.78K$63.41K
Virtu financial28.33K0.00%28.33K$25.00K
Vanguard global advisers2.51K-2.51K$3.27K
Signaturefd228.00-228.00$296.00

Sold Out

HolderChange
Citigroup-6.00
Versant capital management-15.00
Blackrock funding, inc. /de-992.00
Riggs asset managment-1.20K
Raymond james financial-9.52K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202635-2.78%3,902,873-3.50%254.38%13-31.58%8166.67%
Dec 31, 202526-18.75%1,915,186-44.57%111.86%11-35.29%3-
Sep 30, 202531-3,426,3710.47%242.60%1645.45%3-50.00%
Jun 30, 202530-3.23%3,379,937-17.03%302.26%9-25.00%716.67%
Mar 31, 20251-73,700--97.29%----

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv283.10K1.70%21.86K
Vanguard US Total Market Shares ETF153.47K1.43%-
Vanguard Institutional Extnd Mkt Idx Tr128.08K0.77%-
Fidelity Extended Market Index92.03K0.55%14.91K
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
Vifag 2002 SICAV30.00K0.23%-
DFA US Small Cap I15.90K0.14%-
Spartan Extended Market Index Pool F21.33K0.13%7.80K
Northern Trust Extended Eq Market Idx19.90K0.12%15.15K
NT Ext Equity Mkt Idx Fd - L19.90K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 23, 2024ELMS STEVE-Buy$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.-Buy$1.77M
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q1--
2024 Q42-
2023 Q2--
2023 Q1--

MRKR Ownership FAQ

Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 25.49%, followed by 5.49% insiders and 69.02% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 35.75%, which Marker Therapeutics falls below.

Who owns the most shares of Marker Therapeutics?

Marker Therapeutics’s largest shareholders are Nea management company (1.63M shares, 10.62%), Blue owl capital lp (554.25K shares, 3.62%), and Aisling capital management lp (325.37K shares, 2.13%). Together, they hold 16.36% of Marker Therapeutics’s total shares outstanding.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 554.25K Marker Therapeutics shares, valued at 720.52K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.70% of its total shares outstanding invested in 283.1K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools